Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alanna Chamberlain

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Trends in Cardiovascular Medicine|October 31, 2020
Mortality in atrial fibrillation. Is it changing?Alvaro Alonso, Zakaria Almuwaqqat, Alanna Chamberlain
The Journal of International Medical Research|July 7, 2022
Inflammatory biomarkers, multi-morbidity, and biologic agingJennifer St Sauver, Walter Rocca, Nathan LeBrasseur, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 22, 2022
Peripheral artery disease and the risk of venous thromboembolismDaniel Sykora, Christine Firth, Marlene Girardo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 17, 2016
Rate of recurrent anaphylaxis and associated risk factors among Olmsted County, Minnesota, residents: A population-based studySangil Lee, Curtis Bashore, Christine M Lohse, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 20, 2026
Time-Critical Cardiovascular Risk After COVID-19: A Population-Based Analysis Across Variant ErasJames F Howick V, Bernard J Gersh, Christopher G Scott, et al.
Journal of the American College of Cardiology|August 14, 2024
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Trends in Cardiovascular Medicine|October 31, 2020
Mortality in atrial fibrillation. Is it changing?Alvaro Alonso, Zakaria Almuwaqqat, Alanna Chamberlain
The Journal of International Medical Research|July 7, 2022
Inflammatory biomarkers, multi-morbidity, and biologic agingJennifer St Sauver, Walter Rocca, Nathan LeBrasseur, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 22, 2022
Peripheral artery disease and the risk of venous thromboembolismDaniel Sykora, Christine Firth, Marlene Girardo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 17, 2016
Rate of recurrent anaphylaxis and associated risk factors among Olmsted County, Minnesota, residents: A population-based studySangil Lee, Curtis Bashore, Christine M Lohse, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 20, 2026
Time-Critical Cardiovascular Risk After COVID-19: A Population-Based Analysis Across Variant ErasJames F Howick V, Bernard J Gersh, Christopher G Scott, et al.
Journal of the American College of Cardiology|August 14, 2024
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
Pageof 1